Multicenter, Randomized, Parallel Study of Angiotensin Receptor Blockade (Olmesartan) on mortality and morbidity in Chronic Hemodialysis Patients Among Okinawa Dialysis Study Group.
Phase of Trial: Phase III
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Antihypertensives
- Indications Cardiovascular disorders; Hypertension
- Focus Therapeutic Use
- Acronyms OCTOPUS
- 25 Jan 2013 Status changed from active, no longer recruiting to completed.
- 25 Jan 2013 Primary endpoint 'Death-rate' has not been met.
- 25 Jan 2013 Primary endpoint 'Cardiovascular-event-rate' has not been met.